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OSTEOPOROSIS IS A MAJOR HEALTH concern in humans, and this disease is characterized by a low bone mineral density (BMD). BMD is an important determinant of bone strength and low BMD is the result of increased bone resorption and decreased bone formation. Osteoporosis leads to increased bone fragility and therefore an increase in fractures with age. Many factors contribute to regulation of BMD in adult life including sex, nutrition, exercise, environment, and genetics. Of the many factors that contribute to attainment and maintenance of bone mass, genetics accounts for up to 80% of the variation in BMD. Through identification of genes that regulate BMD, we can identify potential therapeutic targets to prevent and/or treat osteoporosis.
Several methods have been utilized to determine the role of genetics in regulating BMD. A well-accepted method is the use of quantitative trait locus (QTL) analysis. We and others have identified many chromosomal loci involved in regulating BMD using this method (2-4, 8, 11, 15, 21, 25) . Although this method has successfully identified several chromosomal regions involved in regulating BMD, it requires a large number of mice that take several years to raise, phenotype, and genotype. Recently, a new resource tool, chromosome substitution strains (CSS), has been developed to more efficiently evaluate specific chromosomes that contribute to phenotypic differences between two strains of mice. For this study, we have used the C57BL/6J-Chr # A/J /NaJ consomic set where each chromosome in the host strain, C57BL/6J, was systematically replaced by the A/J donor chromosome (18, 23) . The B.A CSS consist of 21 strains with one strain for each autosome and the two sex chromosomes. These strains of mice have been a useful tool for studying the genetic influence on several phenotypes in mice (23) . Using CSS has several advantages including: 1) linkage crosses between two inbred strains of mice are not necessary; 2) genotyping of the different lines is not necessary; 3) all the mice are produced within the same genetic background; and 4) the CSS can be backcrossed to the host strain (B6) to break-up the donor chromosome for fine mapping. One disadvantage to this method is that it is only available for a limited number of strain combinations, the A/J and B6 strains being one (a set is also available for B6 and PWD -C57BL/6J-Chr# PWD/Ph / ForeJ); however, the advantages far outweigh this restriction.
Because CSS have been successfully used to identify chromosomes involved in regulating many phenotypes (23), we hypothesized that by comparing body composition and bonerelated phenotypes between the CSS strains and the host B6 strain, we could identify A/J chromosomes that harbor genes that regulate the selected phenotypes in adult mice.
MATERIALS AND METHODS
Mice. The C57BL/6J-Chr # A/J /NaJ chromosome substitution strains (B.A CSS) used in our study were originally developed by Nadeau et al. (18) . Briefly, these CSS are C57BL/6J (B6) host mice in which a single B6 chromosome has been replaced with an A/J chromosome. Therefore, there are 21 B.A CSS strains (B.A-1 to 19, -X, and -Y). For our studies, male mice were compared with the host B6 strain. However, for the female mice, the B6 mice were collected at a later date than the other strains. Based on the knowledge that seasonal variation can affect skeletal phenotype, we chose to use B.A-Y strain females as controls for comparison with other female CSS for all phenotypes evaluated. The B.A-Y female strain was derived by breeding B.A-Y males with unrelated B6 females, which resulted in female offspring that are wild type for the B6 chromosome X. Their littermates are the male B.A-Y mice.
Husbandry. Mice were housed in the Genetic Resource Repository at the Jackson Laboratory in groups of three or four of the same sex in polycarbonate cages (324 cm 2 ) on sterilized White Pine shavings until ϳ6 mo of age. Mice were provided free access to acidified water (pH 2.5 with HCl to retard bacterial growth) and NIH31 diet containing 6% fat, 17% protein, Ca:P of 1.5:0.85, plus vitamin and mineral fortification (Purina Mills International, Brentwood, MO). The full composition of this open formula diet is available at www.labdiet. com/indexlabdiethome.htm. All procedures involving mice were reviewed and approved by the Institutional Animal Care and Use Committee of The Jackson Laboratory.
Dual energy X-ray densitometric analyses of areal bone mineral density and percent body fat. At 6 mo of age, mice (n ϭ 6 to 18/strain) were necropsied for trunk blood samples, followed by determination of whole body composition data (lean, fat, bone mineral) using the PIXImus dual energy X-ray densitometer (DEXA) as described below. Serum was extracted from the blood samples and stored at Ϫ70°C until analysis was performed. Data for body fat and areal bone mineral density (aBMD) were collected using the PIXImus small animal DEXA system (software version 1.43.036.008; PIXImus, Fitchburg, WI). The PIXImus has been reconfigured with lower X-ray energy than in human DEXA machines to achieve contrast in small specimens. The resolution of the PIXImus is 0.18 ϫ 0.18 mm pixels with a usable scanning area of 80 ϫ 65 mm, allowing for measurement of single whole mice and collections of isolated specimens. The PIXImus has been calibrated with a phantom utilizing known values, and a quality assurance is performed daily with this same phantom. Assessment of accuracy for the PIXImus was done with a set of hydroxyapatite standards (0 -2,000 mg), yielding a correlation of 0.999 between standards and PIXImus measurement of mineral. The precision for aBMD is excellent, Ͻ1% for whole body, ϳ1.5% for specialized regions. Correlation with peripheral quantitative computerized tomography (pQCT) values for 614 isolated spinal vertebrae is significant (P Ͻ 0.001; r ϭ 0.704). These data were acquired from euthanized mice.
Serum insulin-like growth factor-I RIA. Insulin-like growth factor-I (IGF-I) was measured by RIA using rabbit polyclonal antiserum and recombinant IGF-I as standard and tracer, respectively. IGFBP were removed from serum prior to RIA by acid gel filtration protocol (16) .
Statistical analysis. Male and female data were analyzed separately by ANOVA, and each CSS was compared with the control host strain (females vs. B.A-Y and males vs. B6) using the Dunnett test. ANOVA and correlation analysis were performed using Statistica 6 software (StatSoft, Tulsa, OK). Data are expressed as a percentage of the control strain and presented as means Ϯ SE. A significant difference was determined at P Յ 0.05.
RESULTS
Body weight. Several A/J chromosomes contributed to variations in body weight (BW) in both male and female mice (Fig. 1) . Specifically, male A/J mice were smaller (77%) than B6 mice (P ϭ 0.001). Similarly, in male B.A-3, 4, 8, 9, 12, and 18, BW was 79 -85% of male B6 (P Ͻ 0.05). In contrast, BW was 119% of B6 in male B.A-5 (P ϭ 0.01). Although female A/J mice have a similar BW compared with B.A-Y (P ϭ 0.99), female B.A-3, 4, and 11 were 73-81% (P Ͻ 0.01), and B.A-13 were 120%, respectively (P Ͻ 0.05), of B.A-Y females.
Total body fat. Although a significant difference in body fat was not observed between male A/J and B6 mice (P ϭ 0.87), B.A-5 was 172% compared with B6 males (P Ͻ 0.001, Fig. 2 ). In females, B.A-13 were 182% of female B.A-Y mice (P Ͻ 0.01) for body fat, and B.A-3, 4, 10, and 11 were reduced 34 -47% compared with B.A-Y females (P Ͻ 0.05).
aBMD. Total body aBMD was less in both male (86%) and female (92%) A/J mice compared with controls (P Ͻ 0.05, Fig. 3 ). Consistent with these data, aBMD was reduced in male B.A-1, 2, 6, 9, 10, 11, and 18 (90 -95%, P Ͻ 0.05) and reduced in female B.A-8, 9, and 10 (92-96%, P ϭ 0.05). Interestingly, aBMD was greater in female B.A-14 (107%, P Ͻ 0.001) compared with B6 females.
Serum IGF-I. To determine if circulating IGF-I is regulated by specific chromosomes in A/J and B6 mice, we determined serum concentrations of IGF-I in all CSS (Fig. 4) . Although we did not observe a significant difference between male A/J and B6 mice (P ϭ 0.91), B.A-14 and -Y had greater IGF-I (136 and 120%, respectively) and B.A-3 had reduced IGF-I (80%) compared with male B6 (P Ͻ 0.05). Surprisingly, female B6 mice exhibited 30% lower serum IGF-I compared with female B.A-Y although both of these lines are genetically identical. Because female B6 mice were generated at a later time com- Correlations. To determine if certain phenotypes are significantly correlated with each other, we performed correlation analysis. As expected, aBMD (R ϭ 0.26 and 0.41), serum IGF-I (R ϭ 0.21 and 0.26), and body fat (Rϭ0.89 and 0.90) were positively correlated with BW in both male and female mice, respectively (P Ͻ 0.01 for all). Serum IGF-I was positively correlated with body fat in both males and females (R ϭ 0.19 and 0.20, P Ͻ 0.01). Interestingly, aBMD was positively correlated with serum IGF-I and body fat in female mice (R ϭ 0.22 and 0.34, P Յ 0.001), but not in males (P Ն 0.11).
DISCUSSION
Maintenance of optimal BMD in adulthood is critical to preventing the onset of osteoporosis; however, the mechanisms involved in maintaining BMD are not well understood. To further elucidate the mechanisms involved in regulating BMD, we utilized a novel approach to begin to identify chromosomes that contribute to variations in BMD in adult mice. Specifically, we evaluated BMD in A/J and B6 mice and determined that BMD is reduced in A/J male and female mice compared with B6. On the basis of this knowledge and the efficiency of the CSS model, we chose to use this method for identification of chromosomes that contribute to this difference in these two inbred strains of mice. Using these unique strains of mice, we have provided the first data demonstrating specific A/J chro- Data were analyzed by ANOVA and Dunnett's Test. *Significant difference from control at P Յ 0.05; #tendency for a difference from control at P Յ 0.10. 2 , respectively. Data were analyzed by ANOVA and Dunnett's Test. *Significant difference from control at P Յ 0.05. mosomes involved in regulating BMD and serum IGF-I in adult mice. Not only is this method more efficient than traditional QTL analysis, but it can be used to identify novel QTLs, as well as confirm previous findings in other strains. In addition, due to random segregation and gene-gene interaction, differences can be identified in CSS even if the parental strains are not different. In the past decade, several studies in humans and mice have identified numerous QTLs for various bonerelated phenotypes. Many of these studies also identified specific candidate genes for osteoporosis-related phenotypes, which are elaborately summarized by Liu et al. (13, 14) . Using our CSS model, we were able to confirm several previously identified QTL for aBMD as discussed below.
In our study we found several A/J chromosomes that contribute to smaller BW in the males. In addition, several chromosomes in the female A/J mice regulate BW in the B6 background, thus suggesting that genes on these chromosomes may be suppressed in the A/J background. Several previous studies have utilized the QTL approach in various inbred strains of mice and identified several chromosomal regions involved in mediating BW and body composition in mice (24) . Similar to these studies, we determined that several chromosomes are involved in mediating BW; however, not all are associated with body fat. Of the 10 B.A CSS that have BW different from controls, only 6 have a similar change in body fat. These findings suggest that some of the changes in BW are associated with other factors such as body water, lean, or mineral mass in adult mice. In support of this, further analysis determined that lean mass was positively correlated with body weight (r ϭ 0.8071 and 0.8895 for males and females, respectively; P Ͻ 0.0001), however, BMC was not correlated with body weight (P Ն 0.17). In addition, 6 of the 10 B.A. CSS for BW were also identified for lean body mass (data not shown). A previous meta-analysis of several QTL studies identified chromosomes 1, 2, 7, 11, 15, and 17 as prominent chromosomes involved in regulating BW and body fat (24) . Similarly, we identified A/J chromosome 11 as a regulator of BW and body fat in female mice. It would not be expected that all crosses would identify the same QTL for any given phenotype. Since inbred strains vary in their genomic polymorphisms, the QTL discovered in a given cross will be specific to the genetic differences between the progenitor strains.
We identified several chromosomes in male and female A/J mice that regulate aBMD in both a positive and negative manner. These findings are consistent with published QTL studies involving various inbred strain crosses that reveal evidence for multiple genetic loci contributing to BMD variation (13, 14) . Similar to a previous study in our laboratory (15), we identified chromosome 9 in both male and female mice as a regulator of aBMD. We also identified chromosome 1 to regulate aBMD in a sex-dependent manner. Other studies have shown evidence for the presence of sex-specific BMD QTL in chromosome 1 (7). However, there are some chromosomes identified in previous studies that we did not determine as regulators of aBMD and vice versa (11, 15) . This is not surprising based on BMD QTL studies in various inbred strain crosses of mice that have shown evidence for both common and unique QTL for individual crosses. These differences may be due to the different inbred strains of mice used as well as the different ages of the mice. Alternatively gene-gene interactions may be different depending on the genetic background. To determine if A/J chromosomes contain genetic loci that regulate aBMD independent of BW, body fat, or lean body mass we adjusted aBMD for these factors and identified several chromosomes in both males and females that regulate aBMD in a positive or negative manner (Table 1) . Interestingly, we identified chromosome 4 in both males and females as a positive regulator of aBMD independent of BW, body fat, or lean body mass. These findings are consistent with previous reports in other inbred strains of mice (1, 17, 20) , thus suggesting that a gene or genes found on this chromosome are critical to maintaining aBMD in mice.
To determine if A/J chromosomes that regulate aBMD and body composition also contribute to variation in serum IGF-I, we evaluated circulating concentrations of IGF-I in CSS mice. Surprisingly, several chromosomes associated with aBMD also (5, 9, 10, 22) . We also identified several of these chromosomes, 3, 6, and 8, in male and/or female mice. Surprisingly, we did not identify a contribution by chromosome 10, on which the mouse IGF-I gene is located. Previous studies using B6-C3H/HeJ intercross have narrowed down the chromosome 10 IGF-I QTL region to 18.3 Mb containing 148 genes (5, 22) . The serum differences in IGF-I between B6 and C3H/HeJ mice could be due to allelic differences in IGF-I gene itself or other gene(s) within the 18.3 Mb region. If IGF-I is the chromosome 10 QTL gene, we would then predict allelic differences in the regulatory regions of IGF-I gene between B6-C3H/HeJ but not between B6-A/J strain pairs. Our search for single nucleotide polymorphism (SNP) differences among the three strains in the IGF-I gene using available databases (http://phenome.jax.org/pub-cgi/phenome/mpdcgi?rtnϭdocs/ home) revealed four and six SNPs respectively between B6 and C3H/HeJ and between B6 and A/J. However, there was only a single SNP between B6 and AJ and none between B6 and C3H/HeJ in the regulatory region, thus suggesting that other genes located in the QTL region of chromosome 10 may be responsible for regulating serum IGF-I. It is also possible that we did not observe a contribution of chromosome 10 because of the different ages of the mice used in each study.
Several genetic factors can influence the phenotypes observed for each chromosome. For example, several studies have identified sex-specific effects of certain QTLs for BMD and femoral cross-sectional area (6, 7, 12, 19) . Therefore it is critical to evaluate males and females separately, as to avoid eliminating or accentuating certain QTLs identified (6) . Based on our analysis of males and females separately, we identified several chromosomes which regulate BW, body fat, aBMD, and IGF-I that are sex dependent or independent. In addition to novel genes, these sex effects could be associated with effects of sex steroid regulation. In addition, gene-gene interaction on a particular chromosome can also contribute to differences between these CSS. Further studies are needed to identify specific genes involved in regulating these phenotypes and identify if any gene-gene interaction(s) occurs.
QTL studies not only identify chromosomal regions involved in regulating specific phenotypes, such as aBMD, they also generate potential candidate genes. For example, several well-studied genes associated with osteoporosis, as well as several novel genes identified in previous QTL studies were identified in our CSS (13) . To identify specific genes within the loci identified for each chromosome in our model, we plan to backcross selected B.A consomic strains to the B6 host strain to precisely locate the causative genes. However, we have done a preliminary search for potential candidate genes by looking for genes within each chromosome that are known to be involved in regulating aBMD. Specifically, we looked at genes located on chromosome 4 that demonstrated a BW-independent effect on BMD in both male and female mice. We identified seven genes (liver alkaline phosphatase; bone morphogenic protein 8b; disheveled 1; leptin receptor; pregnancyassociated plasma protein a; runt-related transcription factor 1 translocated to 1; and runt-related transcription factor 3) known to be involved in bone maintenance, that contain several SNPs that are different between A/J and B6 mice. These findings demonstrate the effectiveness of our model to identify potential candidate genes.
Because a large number of chromosomes were evaluated in this study, there remains a possibility that one or more of the chromosomes identified for phenotypes studied could represent false positives. We will therefore use a number of criteria to select chromosomes for future studies on gene identification which include: 1) the significance level for the CSS of interest; 2) magnitude of phenotypic change for the CSS of interest; 3) phenotypic change in both sexes; 4) confirmation of chromosome identified by published QTL studies for phenotype of interest; and 5) the extent of SNP and candidate gene information on chromosome of interest. We believe that prioritization of CSS based on multiple well-reasoned criteria will reduce the likelihood of focusing on false positives for future fine mapping and gene identification work.
In summary, the CSS model provides a unique and efficient mechanism to identify potential genes involved in mediating specific phenotypes, such as aBMD. Overall, our findings suggest that multiple genes are involved in regulating adult aBMD, body fat and serum IGF-I. Further studies, in which CSS are crossed with B6 mice, are needed to identify the specific genes involved in regulating aBMD, body fat, and IGF-I. 
